Search

Abstract: Background: Chronic obstructive pulmonary disease (COPD) is often accompanied by acute exacerbations. Patients of COPD exacerbation suffering from respiratory failure often need the support of mechanical ventilation. Helium–oxygen can be used to reduce airway resistance during mechanical ventilation. The aim of this study is to evaluate the effect of helium–oxygen‐assisted mechanical ventilation on COPD exacerbation through a meta‐analysis. Methods: A comprehensive literature search through databases of Pub Med (1966∼2016), Ovid MEDLINE (1965∼2016), Cochrane EBM (1991∼2016), EMBASE (1974∼2016) and Ovid MEDLINE was performed to identify associated studies. Randomized clinical trials met our inclusion criteria that focus on helium–oxygen‐assisted mechanical ventilation on COPD exacerbation were included. The quality of the papers was evaluated after inclusion and information was extracted for meta‐analysis. Results: Six articles and 392 patients were included in total. Meta‐analysis revealed that helium–oxygen‐assisted mechanical ventilation reduced Borg dyspnea scale and increased arterial PH compared with air–oxygen. No statistically significant difference was observed between helium–oxygen and air–oxygen as regards to WOB, PaCO2, OI, tracheal intubation rates and mortality within hospital. Conclusions: Our study suggests helium–oxygen‐assisted mechanical ventilation can help to reduce Borg dyspnea scale. In terms of the tiny change of PH, its clinical benefit is negligible. There is no conclusive evidence indicating the beneficial effect of helium–oxygen‐assisted mechanical ventilation on clinical outcomes or prognosis of COPD exacerbation. [ABSTRACT FROM AUTHOR]

Background: Temporal heterogeneity in human epidermal growth factor receptor 2 (HER2) status may be associated with the prognosis of breast cancer. We aimed to clarify the relationship of HER2-low transition during neoadjuvant therapy with survival outcomes under the new classification of HER2 status., Methods: This retrospective study was conducted based on the prospective database of breast cancer patients treated with neoadjuvant therapy from September 2013 to August 2020., Results: This analysis enrolled 185 patients, including 44 patients with HER2-zero tumours, 93 patients with HER2-low tumours and 48 patients with HER2-positive tumours after neoadjuvant therapy. Nearly, 57.6% of HER2-zero tumours turned into HER2-low tumours after neoadjuvant therapy, while 25.0% of HER2-low patients changed to HER2-zero or HER2-positive tumours. We found that at least once diagnosis as HER2-low breast cancer was related to hormone receptor status ( p  < .001) and Ki-67 expression ( p  = .036). Patients ever diagnosed as HER2-low tumours had favourable clinicopathological features (less Ki-67 expression, lower pathological staging, etc.) as well as significantly better locoregional relapse-free survival (LRFS; p  = .007) and overall survival (OS; p  = .026) compared with those never exhibiting HER2-low expression. Furthermore, the 6-year OS rates were 94.2% (95% confidence interval (CI) 83.1-98.1), 88.7% (74.4-95.2) and 78.1% (65.4-86.6) for patients with stable, once and none HER2-low expression, respectively (adjusted HR, 0.514 [95%CI, 0.294-0.897], p  = .019)., Conclusions: Our study first indicated in patients across all expression levels of HER2 that stable or at least once HER2-low status may confer favourable attributes including less malignant biological behaviour and long-term survival benefit for breast cancer receiving neoadjuvant therapy.

Lung adenocarcinoma (LUAD) is the most common type of lung cancer and is characterized by a high death rate and a poor prospect for survival. Anoikis, which is a kind of programmed cell apoptosis, is an important factor in the advancement of tumors. Nonetheless, the function of anoikis-related lncRNAs (ARLRs) in LUAD is still not well understood. The TCGA database was queried for genomic and clinical information. A prognostic signature for ARLRs was established via the use of coexpression analysis and Cox regression. Validation of the model's accuracy was conducted utilizing K-M curves and receiver operating characteristic (ROC) curves, and the signature was utilized to develop a nomogram. LncRNAs were implicated in the progression of tumors, as determined by functional enrichment analysis. There was an improvement in prognosis, increased immune cell infiltration, and higher immune scores among the low-risk patients. Additionally, we found that the two groups had varied anticancer drug sensitivities, which could help guide treatment. The impact of one ARLR, AC026355.2, on migration and invasion was validated by in vitro experiments in LUAD cells. Herein, a new lncRNA signature associated with anoikis was identified and estimated, potentially serving as a prognostic indicator for LUAD patients.

Chiral carboxylic acid production from renewable biomass by chemocatalysis is vitally important for reducing our carbon footprint, but remains underdeveloped. We herein establish a strategy that make use of a stereogenic center of biomass to achieve a rare example of D-glyceric acid production with the highest yield (86.8 %) reported to date as well as an excellent ee value (>99 %). Unlike traditional asymmetric catalysis, chiral catalysts/additives are not required. Ample experiments combined with quantum chemical calculations established the origins of the stereogenic center and catalyst performance. The chirality at C4 in D-xylose was proved to be retained and successfully delivered to C2 in D-glyceric acid during C-C cleavage. The remarkable cooperative-roles of Ag + and Ag 0 in the constructed Ag/γ-Al 2 O 3 catalyst are disclosed as the crucial contributors. Ag + was responsible for low-temperature activation of D-xylose, while Ag 0 facilitated the generation of active O* from O 2 . Ag + and active O* cooperatively promoted the precise cleavage of the C2-C3 bond, and more importantly O* allowed the immediate fast oxidization of the D-glyceraldehyde intermediate to stabilize D-glyceric acid, thereby inhibiting the side reaction that induced racemization. This strategy makes a significant breakthrough in overcoming the limitation of poor enantioselectivity in current chemocatalytic conversion of biomass., (© 2024 Wiley-VCH GmbH.)

Lignocellulosic biomass as a potential alternative to fossil resource for the production of valuable chemicals and fuels has attracted substantial attention, while reducing the recalcitrance of lignocellulosic biomass is still challenging due to the complex and cross-linking structure of biomass. Solvent system plays important roles in the pretreatment of lignocellulose, enabling the transformation of solid biomass to liquid fluid with better mass and heat transfer, as well as in the selective formation of target products. In particular, H 2 O/tetrahydrofuran (H 2 O/THF) system has recently been widely applied in lignocellulose valorization, which has been proved to exhibit outstanding efficiency for the conversion of lignocellulose, solubilization of the intermediates and products, and shifting reaction equilibrium, thereby significantly improving the yield and selectivity of target products, as well as the full utilization of lignocellulose. In addition, THF shows low toxicity, and is known as a renewable solvent which can be produced from bio-derived chemicals. Herein, this review concentrates on the advances of H 2 O/THF system in lignocellulose valorization in recent years. Several aspects relative to the roles of H 2 O/THF system are discussed as follows: the pretreatment of lignin, conversion of hemicellulose and cellulose components in lignocelluloses, and the promoting formation of valuable chemicals like furfural, 5-hydroxymethyl furfural (HMF), levulinic acid, and so on, as well as the inhibiting role in humins formation. This review might provide useful information for the design of effective solvent system in full utilization of lignocellulosic biomass., (Copyright © 2020 Li, Zhang, Xu and Hu.)

Objective: To study the effects of artemether and dihydroarteannuin on the mouse model of scleroderma., Method: Sixty mice were randomly divided into 8 groups: PBS control group, model group, menstruum group (20% Tween-80, 0.4%CMC-Na), positive medicine group (penicillamine 200 mg kg(-1)), low-dose artemether group (5 mg kg(-1)), high-dose artemether group (20 mg kg(-1)), low-dose dihydroarteannuin group (5 mg kg(-1)), high-dose dihydroarteannuin group (25 mg kg(-1)). We have established a mouse model for scleroderma in Balb/c mice by subcutaneous injections of bleomycin 0.1 mL per day (200 mg L(-1) BLM) for 3 weeks. Meanwhile, the administration lasted for 4 weeks. The back skin was removed in the next day after the final administration. Treated skins and lungs were harvested and analyzed for histological sclerosis. The thickness of the skin and fibrosis degree of derma were observed and made an analysis of the contents of collagen and hydroxyproline., Result: Compared with the model groups, the high-dose groups markedly inhibited the thickness of derma (P<0.001), furthermore, the contents of collagen and hydroxyproline in the skin were also significantly reduced (P<0.05). Other groups of mice showed improvement on scleroderma., Conclusion: Our results suggest that administration of artemether or dihydroarteannuin may be an effective approach in preventing systemic sclerosis.